31.05.2024


The Corallopyronin A team, led by Prof. Dr. Achim Hörauf, has succeeded in acquiring funding for the further preclinical development of the antibiotic corallopyronin A. In partnership with the Japanese pharmaceutical company Eisai, the Helmholtz Centre for Infection Research Braunschweig/Saarbrücken and the University of Bonn, the team has put together a research program to successfully take corallopyronin A into clinical phase 1.

please have a look at the links below :

https://www.ghitfund.org/newsroom/press/detail/433/en

 

https://www.dzif.de/en/new-antibiotic-against-river-blindness-and-lymphatic-filariasis-pathogens

 

https://www.uni-bonn.de/de/neues/neues-antibiotikum-gegen-erreger-der-flussblindheit-und-lymphatischen-filariose

 

https://idw-online.de/de/image392518